EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advancing chemical safety assessment through an omics-based characterization of the test system-chemical interaction

Giusy Del Giudice, Giorgia Migliaccio, Nicoletta D'Alessandro, Laura Aliisa Saarimäki, Marcella Torres Maia, Maria Emilia Annala, Jenni Leppänen, Lena Mӧbus, Alisa Pavel, Maaret Vaani, Anna Vallius, Laura Ylä-Outinen und 2 weitere

Frontiers in Toxicology · 09.11.2023 · 5

DOI: 10.3389/ftox.2023.1294780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Toxicology, online erschienen am 09.11.2023. Verfasst von Giusy Del Giudice und 13 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Assessing chemical safety is essential to evaluate the potential risks of chemical exposure to human health and the environment. Traditional methods relying on animal testing are being replaced by 3R (reduction, refinement, and replacement) principle-based alternatives, mainly depending on in vitro test methods and the Adverse Outcome Pathway framework. However, these approaches often focus on the properties of the compound, missing the broader chemical-biological interaction perspective. Currently, the lack of comprehensive molecular characterization of the in vitro test system results in limited real-world representation and contextualization of the toxicological effect under study. Leveraging omics data strengthens the understanding of the responses of different biological systems, emphasizing holistic chemical-biological interactions when developing in vitro methods. Here, we discuss the relevance of meticulous test system characterization on two safety assessment relevant scenarios and how omics-based, data-driven approaches can improve the future generation of alternative methods.

Schlagwörter

Stichwörter der Autor:innen

AOPchemical safety assessmentchemical-biological interactionmechanism of actionnanosafetynew approach methodologiestest system characterizationtoxicogenomics

Autor:innen und Institutionen

  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland.
  • BioMediTech Unit, Tampere University, Tampere, Finland.
  • Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
  • Tampere Institute for Advanced Study, Tampere University, Tampere, Finland.

Zitieren

APA

Del Giudice, G., Migliaccio, G., D'Alessandro, N., Saarimäki, L. A., Torres Maia, M., Annala, M. E., Leppänen, J., Mӧbus, L., Pavel, A., Vaani, M., Vallius, A., Ylä-Outinen, L., Greco, D., & Serra, A. (2023). Advancing chemical safety assessment through an omics-based characterization of the test system-chemical interaction. Frontiers in Toxicology, 5. https://doi.org/10.3389/ftox.2023.1294780

Vancouver

Del Giudice G, Migliaccio G, D'Alessandro N, Saarimäki LA, Torres Maia M, Annala ME, et al. Advancing chemical safety assessment through an omics-based characterization of the test system-chemical interaction. Frontiers in Toxicology. 2023;5. doi:10.3389/ftox.2023.1294780

BibTeX
@article{DelGiudice2023,
  author = {Del Giudice, Giusy and Migliaccio, Giorgia and D'Alessandro, Nicoletta and Saarimäki, Laura Aliisa and Torres Maia, Marcella and Annala, Maria Emilia and Leppänen, Jenni and Mӧbus, Lena and Pavel, Alisa and Vaani, Maaret and Vallius, Anna and Ylä-Outinen, Laura and Greco, Dario and Serra, Angela},
  title = {Advancing chemical safety assessment through an omics-based characterization of the test system-chemical interaction},
  journal = {Frontiers in Toxicology},
  year = {2023},
  volume = {5},
  doi = {10.3389/ftox.2023.1294780}
}
Kostenlos starten →